Sex and drugs: comment on "Evidence for involvement of erbeta and rgs9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior" by Silverman and Koenig.
Wood
Ruth I
RI
Department of Cell and Neurobiology, Keck School of Medicine at the University of Southern California, Los Angeles, CA 90033, USA. riw@usc.edu
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002755:Choice Behavior / Q000187:drug effects*; D004357:Drug Synergism; D004958:Estradiol / Q000494:pharmacology*; D047629:Estrogen Receptor beta / Q000502:physiology*; D005260:Female; D006801:Humans; D013287:Illicit Drugs; D008297:Male; D020710:RGS Proteins / Q000502:physiology*; D051381:Rats; D012727:Sex Characteristics
D047629:Estrogen Receptor beta; D013287:Illicit Drugs; D020710:RGS Proteins; C116925:regulator of g-protein signaling 9; D004958:Estradiol; D000661:Amphetamine